$5.85Day Range$6.06
Key Statistics
Market Cap
$23.15M
Shares Outstanding
3.8M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jan 26, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$6.03
Day High
$6.06
Day Low
$5.85
Volume
29.9K
VWAP
$5.95
Prev Close
$6.07
Transactions
--
Acc. Volume
--
About Psyence Biomedical Ltd. Common Shares
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Identifiers
- CIK
- 0001985062
- Composite FIGI
- BBG01L71H227
- Share Class FIGI
- BBG01L71H3Y0
- Ticker Root
- PBM
About Psyence Biomedical Ltd. Common Shares (PBM) Stock
Psyence Biomedical Ltd. Common Shares (PBM) closed the 2026-09-16 session at $5.86, down 3.44% versus the previous close (-0.21). The stock opened at $6.03 and traded between $5.85 and $6.06 during that session. Session trading volume was 30K shares. The volume-weighted average price (VWAP) is $5.95.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
Psyence Biomedical Ltd. Common Shares has a market capitalization of $23.2 million. PBM is listed on the XNAS exchange. The company employs approximately 12 people. The recorded listing date is 2024-01-26.
On this page you can find market PBM stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors.